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Objectives. This study evaluated how variations in atrioventric-
ular (AV) delay affect hemodynamic function in patients with
refractory heart failure being supported with intravenous inotrop-
ic and intravenous or oral inodilating agents.
Background. Although preliminary data have suggested that
dual-chamber pacing with short AV delays may improve cardiac
function in patients with heart failure, detailed Doppler and
invasive hemodynamic assessment of patients with refractory New
York Heart Association class IV heart failure has not been
performed.
Methods. Nine patients with functional class IV clinical heart
failure had Doppler assessment of transvalvular flow and right
heart catheterization performed during pacing at AV delays of
200, 150, 100 and 50 to 75 ms.
Results. Systemic arterial, pulmonary artery, right atrial and
pulmonary capillary wedge pressures, cardiac index, systemic and
pulmonary vascular resistances, stroke volume index, left ventric-
ular stroke work index (SWI) and arteriovenous oxygen content
difference demonstrated no significant changes during dual-
chamber pacing with AV delays of 200 to 50 to 75 ms. There were
also no changes in the Doppler echocardiographic indexes of
systolic or diastolic ventricular function. The study was designed
with SWI as the outcome variable. Assuming a clinically signifi-
cant change in the SWI of 5 g/min per m2, a type I error of 0.05
and the observed standard deviation from our study, the observed
power of our study is 85% (type II error of 15%).
Conclusions. Changes in AV delay between 200 and 50 ms
during dual-chamber pacing do not significantly affect acute
central hemodynamic data, including cardiac output and systolic
or diastolic ventricular function in patients with severe refractory
heart failure due to dilated cardiomyopathy.
(J Am Coll Cardiol 1997;30:1295–300)
©1997 by the American College of Cardiology
The increasing incidence of congestive heart failure, as well as
the limited supply of donor hearts available for transplanta-
tion, reinforces the need to find therapeutic modalities to
improve cardiac function in patients with advanced heart
failure (1,2). Patients with refractory heart failure have wors-
ening symptoms or hemodynamic data despite optimal therapy
with digoxin, diuretic agents and angiotensin-converting en-
zyme inhibitors or hydralazine/nitrates. They have a particu-
larly poor prognosis and frequently require immediate phar-
macologic or nonpharmacologic interventions for stabilization
(3). Preliminary data have suggested that dual-chamber pacing
with short atrioventricular (AV) delays may improve cardiac
function in patients with heart failure, especially those with a
long PR interval or diastolic AV valve regurgitation (4–8). We
designed this study to determine how variations in AV delay
affect hemodynamic data and ventricular systolic and diastolic
function in patients with refractory heart failure due to dilated
cardiomyopathy.
Methods
Study patients. The study included 9 patients (5 men and 4
women, mean age 69 6 7 years) with refractory congestive
heart failure (New York Heart Association functional class
IV). Five patients had ischemic heart disease and four patients
had idiopathic dilated cardiomyopathy. All patients had symp-
toms of fatigue and dyspnea with radiologic evidence of
pulmonary venous congestion and cardiomegaly. All patients
were in the cardiac intensive care unit for treatment of
congestive heart failure at the time of the study. Long-term
medications included digoxin (n 5 7), diuretic drugs (n 5 8),
angiotensin-converting enzyme inhibitors (n 5 4), hydralazine/
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nitrates (n 5 5) and amiodarone (n 5 8). Short-term medica-
tions used for cardiac decompensation included dobutamine/
dopamine (n 5 2), dobutamine/dopamine/norepinephrine
(n 5 1), dobutamine/dopamine/norepinephrine/milrinone
(n 5 1), dobutamine plus oral enoximone (n 5 1) and oral
enoximone (n 5 1).
Five of the patients had permanent dual-chamber pacemak-
ers at the time of the study, and four patients had temporary
right atrial and right ventricular atrial pacing catheters placed
for the study. The baseline cardiac rhythm at the time of study
was sinus rhythm in one patient (PR interval 188 ms), sinus
rhythm with first-degree heart block in one patient (PR
interval 440 ms), bigeminy in one patient, third-degree heart
block in two patients and dual-chamber pacing in four patients
(AV delays of 110, 120, 200 and 200 ms, respectively). Of the
two patients in third-degree heart block, one had a stable
escape rate with temporary pacing leads in place while awaiting
permanent pacemaker placement, and one had a permanent
dual-chamber system with a stable junctional escape as an
underlying rhythm. The indications for pacing in the five
patients with preexisting permanent dual-chamber pacing sys-
tems at the time of study were complete heart block in three
patients, symptomatic sinus bradycardia in one patient and AV
junction ablation for paroxysmal atrial fibrillation in one
patient.
Study protocol. The study was approved by the Committee
on Human Research, and written, informed consent was
obtained from each patient. Patients were studied in a nonse-
dated, postabsorptive state in a supine position. Each patient
had a 7F triple lumen balloon flotation catheter for measure-
ment of right atrial, pulmonary artery and pulmonary capillary
wedge pressures (PCWP). Mixed venous oxygen saturations
were obtained from the right atrial port of this catheter.
Cardiac output was determined in triplicate by the thermodi-
lution method. A radial artery catheter was used to measure
arterial pressure directly as well as to obtain arterial oxygen
saturation. Oxygen saturations were measured using a Radi-
ometer OSM2 Hemoximeter.
In the four patients without preexisting pacemakers, a 7F
bipolar atrial J pacing catheter was placed in the right atrial
appendage and a 7F bipolar catheter was placed in the apex of
the right ventricle under fluoroscopic guidance using the right
internal jugular or femoral vein approach. In patients with
temporary pacing wires, a Medtronic 5330 AV Sequential
Demand Pulse Generator was used to program AV delay. All
patients with preexisting dual-chamber pacemakers had pacing
leads in the right atrial appendage and right ventricular apex
positions.
Echocardiographic studies were performed according to the
recommendations of the American Society of Echocardiogra-
phy (9,10) using the Acuson 128XP Ultrasound system with a
2.5-MHz transducer. Care was taken to obtain Doppler signals
with the highest audible frequency, maximal velocity and a
clearly defined envelope. Color Doppler imaging data pro-
vided helpful guidelines for obtaining the optimal continuous
and pulsed wave Doppler curves at a sweep speed of 100 mm/s.
Echocardiographic data were recorded on the SVHS videotape
and measured off-line with a Freeland computer analysis
system interfaced to a videotape recorder.
Patients underwent Doppler assessment of transvalvular
flow and invasive hemodynamic measurement during right
atrial and right ventricular apex pacing at AV delays of 50 to
75, 100, 150 and 200 ms. The order of AV delay was random-
ized with hemodynamic and echocardiographic measurements
performed after a 10-min equilibration period. Pacing was
performed at a minimum of 10 beats/min above the rest rate,
with further increases in pacing rate only in patients in whom
consistent capture was not achieved. This rate was maintained
at all AV delay settings in each individual patient.
Measurements. Invasive hemodynamic data. Hemody-
namic measures included heart rate, systemic systolic and
diastolic blood pressures, right atrial pressure (RAP), pulmo-
nary artery systolic and diastolic blood pressures, PCWP,
cardiac output and arterial and venous oxygen saturations.
Derived systemic hemodynamic data were calculated as fol-
lows: stroke volume index (SVI [ml/m2]) 5 CI/HR, where CI 5
cardiac index and HR 5 heart rate; stroke work index (SWI,
g/m per m2) 5 SVI 3 (MSP 2 PCWP) 3 0.0136, where
MSP 5 mean systolic arterial pressure; system vascular resis-
tance (SVR [dyneszszcm25]) 5 (MAP 2 RAP)/CO 3 80,
where MAP 5 mean arterial pressure and CO 5 cardiac
output; pulmonary vascular resistance (PVR [dyneszszcm25]) 5
(MPAP 2 PCWP)/CO 3 80, where MPAP 5 mean pulmonary
artery pressure; arterial venous oxygen difference (AVDO2
[vol%]) 5 Arterial oxygen content 2 Venous oxygen content,
where oxygen content 5 percent oxygen saturation 3 hemo-
globin (g/dl) 3 1.34.
Doppler variables. An average 6 to 10 high quality Doppler
signals were used for analysis. The left ventricular and right
ventricular systolic flow variables were measured using pulsed
wave Doppler recordings as described previously (11), and
included left ventricular outflow tract (LVOT) acceleration
time, LVOT ejection time, LVOT velocity–time integral (VTI)
(total area under the LVOT velocity curve as an estimate of
the LVOT stroke volume), pulmonary artery acceleration
time, pulmonary artery ejection time and pulmonary artery
VTI. The severity of the mitral valve regurgitation was graded
using the color Doppler mode as previously described (11).
Abbreviations and Acronyms
AV 5 atrioventricular
AVDO2 5 arteriovenous oxygen content difference
LVOT 5 left ventricular outflow tract
MAP 5 mean arterial pressure
PAP 5 pulmonary artery pressure
PCWP 5 pulmonary capillary wedge pressure
RAP 5 right atrial pressure
SVI 5 stroke volume index
SWI 5 stroke work index
VTI 5 velocity–time integral
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The peak velocity of the mitral regurgitation was measured in
the continuous wave Doppler mode as an index of the left
ventricular–left atrial systolic pressure gradient. The mitral
valve regurgitation acceleration time was measured as the
interval from the beginning to the peak of the mitral regurgi-
tation jet. The presence of diastolic mitral regurgitation was
noted. The change in the systolic right ventricular–right atrial
peak pressure gradient was estimated by the measurement of
the peak tricuspid valve regurgitation velocity.
To estimate the left ventricular and right ventricular dia-
stolic variables, the mitral and tricuspid flow curves were
recorded in the pulsed wave Doppler mode. Both peak E and
A wave flow velocities were measured for the mitral flow, and
the main peak E wave on the tricuspid diastolic flow curve was
measured for the right ventricular flow change. The mitral
valve deceleration time was not able to be measured because of
near fusion of the mitral valve E and A waves. The left and
right ventricular filling times were measured as the interval
from the beginning to the end of the diastolic flow on the
mitral and tricuspid diastolic Doppler curves.
Statistical analysis. Data are expressed as the mean
value 6 SD. A p value ,0.05 was considered significant.
Statistical analysis was performed using repeated measures
analysis of variance for hemodynamic variables and Doppler
variables at AV delay settings of 50 to 75, 100, 150 and 200 ms.
Results
Baseline hemodynamic data included a mean heart rate of
71 6 16 beats/min, MAP 79 6 15 mm Hg, MRAP 11 6
9 mm Hg, MPAP 36 6 8 mm Hg, PCWP 22 6 6 mm Hg,
cardiac index 2.5 6 0.7 liters/min per m2, systemic vascular
resistance 1,363 6 535 dyneszszcm25 and pulmonary vascular
resistance 292 6 214 dyneszszcm25. The mean baseline echo-
cardiographic left ventricular ejection fraction was 28 6 8%
(range 18% to 40%). Diastolic mitral regurgitation was present
in two patients with complete heart block. Semiquantitative
mitral regurgitation grades by echocardiography at baseline
were mild (n 5 1), mild to moderate (n 5 5) and moderate
(n 5 3).
The patients’ hemodynamic variables at AV delays between
200 and 50 ms are shown in Table 1. There were no significant
changes in measured or derived invasive hemodynamic vari-
ables between AV delay settings of 50 to 75, 100, 150 and
200 ms. Doppler assessment of left and right ventricular
systolic function failed to reveal any differences in these
patients at the various AV delays evaluated (Table 2). With the
exception of mitral valve peak A wave velocity, there were no
differences in left and right ventricular diastolic function at the
various AV delays evaluated by Doppler echocardiography
(Table 2). The mitral valve peak A wave velocity was signifi-
cantly better at longer AV delays (p 5 0.03). The diastolic
mitral regurgitation present in two patients with complete
heart block at baseline did not appear at any AV sequential
pacing settings. Assessment of semiquantitative mitral regur-
gitation grade revealed no changes in grade at the studied AV
delay settings.
Discussion
In our study of patients with refractory congestive heart
failure due to dilated cardiomyopathy, dual-chamber pacing at
AV delays of 50 to 200 ms did not immediately change
hemodynamic variables as evaluated by invasive right heart
catheterization. Whether AV delays were short or long, there
were no differences in the SVI, SWI, PCWP or RAP, suggest-
ing that there was no hemodynamic evidence for improvement
in ventricular function with shorter AV delays compared with
Table 1. Acute Hemodynamic Data at Variable Atrioventricular Delays
Atrioventricular Delay (ms)
p
Value
50–75
(n 5 9)
100
(n 5 9)
150
(n 5 9)
200
(n 5 9)
Heart rate (beats/min) 90 6 14 91 6 14 89 6 14 91 6 14 0.25
Systolic blood pressure (mm Hg) 120 6 21 121 6 18 122 6 20 125 6 17 0.37
Diastolic blood pressure (mm Hg) 60 6 7 63 6 8 63 6 10 64 6 10 0.16
Mean arterial pressure (mm Hg) 80 6 10 82 6 10 82 6 11 84 6 11 0.24
Right atrial pressure (mm Hg) 10 6 9 10 6 9 10 6 9 10 6 9 0.98
Pulmonary artery systolic pressure (mm Hg) 62 6 19 66 6 20 62 6 19 63 6 20 0.21
Pulmonary artery diastolic pressure (mm Hg) 24 6 7 27 6 6 25 6 7 26 6 6 0.15
Mean pulmonary artery pressure (mm Hg) 37 6 10 40 6 10 37 6 10 39 6 10 0.15
Pulmonary capillary wedge pressure (mm Hg) 21 6 5 23 6 9 20 6 6 21 6 8 0.51
Stroke volume index (ml/beats per m2) 30 6 11 31 6 13 32 6 13 32 6 12 0.11
Stroke work index (g/min per m2) 25 6 11 26 6 13 28 6 13 27 6 13 0.07
Cardiac output (liters/min) 4.8 6 1.9 4.9 6 2.1 5.0 6 2.2 5.0 6 2.0 0.29
Cardiac index (liters/min per m2) 2.7 6 1.0 2.8 6 1.2 2.9 6 1.2 2.8 6 1.1 0.32
Arteriovenous oxygen saturation difference (dl/liter) 6.0 6 1.3 4.7 6 1.9 5.5 6 1.7 4.9 6 1.1 0.11
Systemic vascular resistance (dyneszszcm25) 1,354 6 602 1,355 6 582 1,347 6 608 1,402 6 703 0.69
Pulmonary vascular resistance (dyneszszcm25) 325 6 230 308 6 184 325 6 237 313 6 148 0.92
Data are presented as mean value 6 SD.
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longer AV delays. The variable that we a priori considered to
be of greatest importance was the SWI. This variable was
chosen because it incorporates information on both pressure
work and volume work and therefore assesses overall ventric-
ular performance. The additional hemodynamic and Doppler
data were analyzed to assess the effect of variable AV delays
specifically on systolic and diastolic ventricular function. A
clinically significant change in SWI was arbitrarily chosen as
$5 g/min per m2. As in our clinical experience, smaller changes
can be seen with a spontaneous variation in this variable.
Assuming a clinically significant change in SWI of 5 g/min per
m2 and a type I error of 0.05 as well as the observed standard
deviation from our study, the observed power of our study is
85% (PASS Version 6.0, NCSS). This study had negative
results with a type II error of 15%.
In our study, Doppler echocardiographic studies confirmed
that AV delays do not influence ventricular performance in
these patients with severe clinical heart failure with marked
hemodynamic abnormalities resulting from dilated cardiomy-
opathy. There were no changes in the indexes of systolic or
diastolic function during pacing with shorter or longer AV
delays. Earlier studies by Hochleitner et al. (4,5) suggested that
dual-chamber pacing at an AV delay of 100 ms improved the
functional class, cardiac dimensions and congestive heart fail-
ure symptoms of 17 patients with advanced heart failure.
One-half of these patients were taking intravenous inotropic
agents at the time of initiating dual-chamber pacing. Of the
paced patients who survived 1 year, the ejection fraction was
significantly improved by pacing (19 6 3% to 30 6 4%), and
there was an unexpectedly long median survival time of the
entire group (22 months). In the first 2 years of pacing, the
ejection fraction fell by 5% to 11% with early withdrawal of
pacing. No invasive hemodynamic studies were performed to
determine the mechanism of improved cardiac performance.
Further evidence to support the use of dual-chamber pacing
in patients with congestive heart failure was provided by
Brecker et al. (6). In 12 otherwise uncharacterized patients
with an unreported severity of heart failure, all of whom had
mitral and/or tricuspid diastolic regurgitation and left or right
ventricular filling times of ,200 ms, Doppler echocardiogra-
phy was used early to assess the physiologic effects of dual-
chamber pacing. Five patients had a prolonged PR interval and
four patients had permanent pacemakers for complete heart
block. At AV delays ,50 ms, all patients had a significant
reduction in mitral and tricuspid regurgitation times and a
significant increase in left ventricular filling times. The group
as a whole had an increase in cardiac output (3.9 to 5.0
liters/min by Doppler analysis) and improved exercise toler-
ance. Invasive hemodynamic studies were not performed. The
investigators concluded that in patients with congestive heart
failure and AV valve diastolic regurgitation, especially with a
prolonged PR interval, dual-chamber pacing with a short AV
delay improves the relation between atrial and ventricular
systole, improves ventricular diastolic filling and leads to
improved forward cardiac output. Guardigli et al. (7) also
demonstrated progressive improvement in transmitral flow in
Table 2. Doppler Assessment of Cardiac and Valvular Function
Doppler Variables
Atrioventricular Delay (ms)
p Value50–75 100 150 200
Left heart
Systolic variables
LVOT acceleration time (s) 0.06 6 0.02 0.07 6 0.02 0.06 6 0.02 0.07 6 0.02 0.53
LVOT ejection time (s) 0.21 6 0.02 0.22 6 0.03 0.21 6 0.03 0.21 6 0.03 0.91
LVOT VTI (m) 0.17 6 0.07 0.16 6 0.07 0.16 6 0.08 0.18 6 0.08 0.36
MR peak velocity (m/s) 4.2 6 0.4 4.4 6 0.1 4.4 6 0.5 4.4 6 0.3 0.35
MR acceleration time (s) 0.15 6 0.02 0.14 6 0.02 0.15 6 0.02 0.16 6 0.04 0.18
MR VTI (m/s) 1.2 6 0.2 1.2 6 0.2 1.3 6 0.2 1.3 6 0.2 0.65
Diastolic variables
MV peak E wave velocity (m/s) 1.0 6 0.3 1.1 6 0.3 1.0 6 0.3 1.1 6 0.2 0.34
MV peak A wave velocity (m/s) 0.6 6 0.4 0.7 6 0.5 0.7 6 0.2 0.9 6 0.3 0.03
MV peak E/A ratio 2.9 6 1.7 6.2 6 8.6 1.5 6 0.7 1.5 6 0.7 0.14
MV filling time (s) 0.28 6 0.06 0.28 6 0.07 0.26 6 0.09 0.26 6 0.05 0.62
Right heart
Systolic variables
PA acceleration time (s) 0.06 6 0.02 0.06 6 0.02 0.06 6 0.02 0.06 6 0.02 0.80
PA ejection time (s) 0.21 6 0.03 0.22 6 0.03 0.22 6 0.02 0.22 6 0.03 0.85
PA VTI (m) 0.12 6 0.04 0.13 6 0.04 0.12 6 0.04 0.13 6 0.05 0.77
TR peak velocity (m/s) 3.2 6 0.4 3.3 6 0.05 3.2 6 0.3 3.2 6 0.3 0.78
Diastolic variables
TV peak E wave velocity (m/s) 0.6 6 0.2 0.7 6 0.3 0.8 6 0.3 0.8 6 0.3 0.11
TV filling time (s) 0.25 6 0.07 0.26 6 0.08 0.25 6 0.07 0.25 6 0.05 0.81
Data are presented as mean value 6 SD. E/A 5 early transmitral flow velocity to atrial flow velocity; LVOT 5 left
ventricular outflow tract; MR 5 mitral regurgitation; MV 5 mitral valve; PA 5 pulmonary artery; TR 5 tricuspid
regurgitation; TV 5 tricuspid valve; VTI 5 velocity–time integral.
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patients with dilated cardiomyopathy as AV delays were
shortened to 80 ms during dual-chamber pacing.
In contrast to these favorable results, Nishimura et al. (8)
evaluated the early hemodynamic effects of dual-chamber
pacing with AV delays ranging from 61 to 240 ms in patients
with moderate congestive heart failure as assessed by cathe-
terization and Doppler echocardiography and reported no
improvement in the systolic or diastolic ventricular function in
the group as a whole with varying AV delays. Furthermore,
there was an increase in tau (time constant of relaxation) from
64 to 73 ms at the 60-ms AV delay (p , 0.01), suggesting that
a very short AV delay may impair left ventricular relaxation.
With retrospective subgroup analysis in eight patients with a
long PR interval (mean 283 6 51 ms), pacing with a shorter
AV interval significantly improved cardiac output (38% in-
crease). Seven of these patients had a baseline short ventricu-
lar filling time and five had a baseline mitral diastolic regurgi-
tation that was abolished by dual-chamber pacing. However, in
the subgroup of seven patients with a normal or short PR
interval, dual-chamber pacing with a shorter AV interval
resulted in a significant decrease in cardiac output (4.2 to 3.4
liters/min, p , 0.01). In the present study also, the SVI, SWI
and cardiac index tended to be lower and the AVDO2 widest
during pacing with an AV delay of 50 to 75 ms, although the
differences were not statistically significant.
Gold et al. (12) assessed acute and chronic dual-chamber
pacing in 12 patients with predominantly functional class III
heart failure with no other indication for cardiac pacing. In the
short term, there were no significant differences in the mean
MAP, RAP, PAP, PCWP or cardiac index, even with analysis
of patients with prolonged PR intervals (mean 242 6 42 ms).
In the chronic pacing portion of the study, a double-blind,
randomized, crossover of 4 to 6 weeks of pacing with an AV
delay of 100 ms compared with VVI pacing at 40 beats/min
demonstrated no significant differences in ejection and clinical
heart failure status.
In another study by Linde et al. (13), 10 patients with
predominantly class III heart failure on a stable medical
regimen underwent pacemaker placement and noninvasive
long-term follow-up after determination of an “optimized” AV
delay based on the acute highest aortic valve VTI. Over a
6-month follow-up period, there was no significant change in
stroke volume, cardiac output, functional class or ejection
fraction. In this study, however, hemodynamic assessments by
catheterization were not performed.
In the present study, the effects of variations in AV delay on
ventricular function were assessed by concurrent right heart
catheterization and Doppler echocardiography in patients with
more severe, truly refractory chronic heart failure. Our study
addressed the issue of whether variations in AV delay between
200 and 50 ms would immediately influence hemodynamic data
in patients with decompensated heart failure. The results
demonstrated that there was no hemodynamic benefit with
shorter or longer AV delays during dual-chamber pacing.
Doppler echocardiography also failed to reveal any improve-
ment in ventricular systolic or diastolic function. In an earlier
study, a shorter AV delay was reported to improve hemody-
namic data, particularly in patients with diastolic AV valve
regurgitation. In this study, in the two patients with diastolic
mitral regurgitation with complete heart block at baseline,
diastolic regurgitation was abolished by all AV delay settings
and shorter versus longer AV delays did not change hemody-
namic data or ventricular function.
In this study, all patients had severe heart failure associated
with not only markedly decreased ejection fraction, but also
with markedly dilated left ventricles and markedly elevated
PCWPs. In patients with elevated PCWP, atrial contribution
does not appear to influence left ventricular function (14). The
failing left ventricle is unable to improve its systolic perfor-
mance in response to an increase in preload because of a lack
of a Frank-Starling reserve (15). Furthermore, because the
failing ventricle functions on the steep portion of the ventric-
ular diastolic pressure–volume curve, possible early changes in
diastolic ventricular pressure caused by even effective atrial
systole would not be expected to significantly change ventric-
ular diastolic volume, even though pressures may increase. In
addition, the presence of coexisting right-sided failure and
pulmonary hypertension may have overshadowed any benefits
to left-sided performance resulting from short AV delay
pacing, as a substantial proportion of measured rest left
ventricular diastolic pressure stems from forces extrinsic to the
left ventricle (right ventricular filling) rather than from dia-
stolic stiffness of the left ventricle itself (16). In the present
study, changes in left or right ventricular volume were not
measured directly during pacing with varying AV delays.
Nevertheless, there were no changes in RAP or PCWP or in
the Doppler echocardiographic filling variables, suggesting
that there were no significant changes in left or right ventric-
ular filling characteristics during pacing in our patients and
possibly explaining the lack of change in systolic function.
Study limitations. The limitations of this study include the
small sample size and the heterogeneity of baseline heart
rhythm, which precluded comparison of baseline hemody-
namic data and Doppler echocardiographic data with those
during pacing with variable AV delays. The scope of our results
therefore pertains specifically to AV delays between 200 and
50 ms in refractory heart failure. Assessment of changes from
extremely prolonged baseline PR intervals to AV delays
,200 ms, as studied by Nishimura et al., was not possible;
therefore, the effect of improved AV synchrony provided by
correcting extremely prolonged PR intervals in this refractory
group of patients could not be assessed. In addition, analysis of
group hemodynamic data and Doppler data at specific AV
delays may not reveal changes, as optimal AV delay may vary
between individual patients. It should be noted that the
hemodynamic data at the average heart rate of 71 beats/min at
baseline were almost identical to those during pacing at ;90
beats/min during variable AV delays, suggesting that it is
unlikely that dual-chamber pacing at any rate with any AV
interval will produce beneficial effects on ventricular systolic or
diastolic function.
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Conclusions. Early changes in AV delay between 200 and
50 ms do not significantly affect cardiac performance as
evaluated by invasive hemodynamic data and detailed Doppler
echocardiographic study in patients with severe heart failure
due to dilated cardiomyopathy. Dual-chamber pacing with
short AV delay pacing cannot be recommended for short-term
treatment of refractory heart failure. Further investigation is
required to assess the long-term hemodynamic effects of
altering AV delay during dual-chamber pacing in patients with
severe heart failure due to dilated cardiomyopathy.
We thank Gunnard Modin for assistance with statistical analysis.
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